Compliance & Efficacy in the Use of PICOPREP®

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The present trial is aimed to document efficacy (bowel cleanliness), acceptance and tolerability as well as patient comfort in the use of the new bowel cleansing product PICOPREP® in every day practice. In particular, it should be evaluated, whether bowel cleanliness, acceptance, tolerability and patient comfort are affected by specific practice procedures, changes in dose etc.

See also
Status	Clinical Trial	Phase
Terminated	`NCT01748591` - Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice	N/A
Completed	`NCT01635725` - New Bowel Preparation Scale for Measuring Colon Cleanliness	N/A
Completed	`NCT01292109` - A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.	N/A

NCT number	NCT01220453
Study type	Observational
Source	Ferring Pharmaceuticals
Contact
Status	Completed
Phase	N/A
Start date	October 2010
Completion date	July 2011

Compliance and Efficacy in the Use of PICOPREP® — CLEAR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms